• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Amgen contract- field access specialist





While this access specialist might be short term I think it's a good opportunity if you handle it right.
Document every success, keep meticulous records, find ways to get recognized and solve problems. Collaborate with the reps. They are potential recommendations for you in the future.
There will be more & more jobs like this as biologics are approved. It's a path with potential.
The sales side has been a nightmare.
 
















































i am on the sales side with this product: hired in Feb and getting laid off 12/31. Some folks on this contract are being let go after only 1 or 2 months in the field. They claim it is territory realignment but the reality is this drug is not selling because very few payers will approve it. Keep your resume updated and keep an eye out for openings. Good luck to all.